HPP737 study in healthy Chinese men
Part of Skin clinical trials.
This study tests how the body processes the experimental drug HPP737 in healthy Chinese men. It helps researchers understand how the drug is absorbed, broken down, and eliminated.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy Chinese male between 18 and 45 years old.
- Your body weight must be at least 110 pounds (50 kg), and your BMI must be between 19 and 26.
- You cannot smoke more than 5 cigarettes a day or drink alcohol in excess.
- You must be willing to use strict birth control during and for 6 months after the trial.
- You cannot have taken any prescription or over-the-counter drugs, herbs, or supplements in the past 14 days.
- You should not have any bleeding problems, gastrointestinal issues, or conditions that affect drug absorption.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine called SPH9788 in healthy people to see how the body handles it. Volunteers must be generally healthy and follow lifestyle rules to help researchers understand the drug's safety and effects.
This study tests how a healthy male body absorbs, uses, and removes a new experimental medication. Researchers track the drug's path through your body using a special radioactive marker to understand how it works and ensure it's safe.
This trial tests a new drug called IPG1094 in healthy people to see if it's safe and how the body handles it. Healthy volunteers may join to help find the right dose for future studies.
This trial tests how Sudapyridine (WX-081) moves through the body in healthy Chinese men. It helps researchers understand the drug's effects and safety before moving to later studies.
This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.
This first-in-human trial tests a new medication called HSK47388 in healthy volunteers to see if it's safe and how the body processes it. If you're generally healthy, you may be able to help researchers understand this potential new treatment.
Hear when a new Psoriasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.